CPT: Pharmacometrics and systems pharmacology

CPT: Pharmacometrics and Systems Pharmacology

Volumn 1, Issue 1, 2012, Pages

  Van Der Graaf, Piet H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; DRUG INDUSTRY; DRUG RESEARCH; INVESTMENT; MATHEMATICAL MODEL; MEDICAL LITERATURE; MEDICAL SOCIETY; PHARMACOLOGY; PRIORITY JOURNAL; REVIEW; SIMULATION;

EID: 84881200963     PISSN: None     EISSN: 21638306     Source Type: Journal    
DOI: 10.1038/psp.2012.8     Document Type: Review

References (32)

1. Ette, E.I. & Williams, P.J. Pharmacometrics: The Science of Quantitative Pharmacology (John Wiley & Sons, Inc., Hoboken, New Jersey, 2007
2. Barrett, J.S., Fossler, M.J., Cadieu, K.D. & Gastonguay, M.R. Pharmacometrics: A multidisciplinary field to facilitate critical thinking in drug development and translational research settings. J. Clin. Pharmacol. 48, 632-649 (2008
3. Lalonde, R.L. et al. Model-based drug development. Clin. Pharmacol. Ther. 82, 21-32 (2007
4. Manolis, E. & Herold, R. Pharmacometrics for regulatory decision making: Status and perspective. Clin. Pharmacokinet. 50, 625-626 (2011
5. Lee, J.Y. et al. Impact of pharmacometric analyses on new drug approval and labelling decisions: A review of 198 submissions between 2000 and 2008. Clin. Pharmacokinet. 50, 627-635 (2011
6. Iyengar, R., Zhao, S., Chung, S.W., Mager, D.E. & Gallo, J.M. Merging systems biology with pharmacodynamics. Sci. Transl. Med. 4, 126ps7 (2012
7. Preusch, P.C. Integrative and organ systems pharmacology: A new initiative from the National Institute of General Medical Sciences. Mol. Interv. 4, 72-73 (2004
8. Van der Greef, J. & McBurney, R.N. Rescuing drug discovery: In vivo systems pathology and systems pharmacology. Nature Rev. Drug Discov. 4, 961-967 (2005
9. van der Graaf, P.H. & Benson, N. Systems pharmacology: Bridging systems biology and pharmacokinetics-pharmacodynamics (PKPD) in drug discovery and development. Pharm. Res. 28, 1460-1464 (2011
10. Systems biology: A vision for engineering and medicine. A report from the Academy of Medical Sciences and The Royal Academy of Engineering (2007). .
11. Sorger, P.K., Allerheiligen, S.R.B., Abernethy, D.R., Altman, R.B., Brouwer, K.L.R., Califano, A. et al. Quantitative and Systems Pharmacology in the Post-genomic Era: New Approaches to Discovering Drugs and Understanding Therapeutic Mechanisms. An NIH White Paper, QSP Workshop Group (2011).
12. Paul, S.M. et al. How to improve R&D productivity: The pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov. 9, 203-214 (2010
13. Morgan, P. et al. Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival. Drug Discov. Today 17, 419-424 (2012
14. Bachman, J.A. & Sorger, P. New approaches to modeling complex biochemistry. Nat. Methods 8, 130-131 (2011
15. Black, J. Reflections on drug research. Br. J. Pharmacol. 161, 1204-1216 (2010
16. Network pharmacology moves into the clinic. Nature Drug Discov. 11, 589 (2012
17. Karr, J.R. et al. A whole-cell computational model predicts phenotype from genotype. Cell 150, 389-401 (2012
18. Rostami-Hodjegan, A. Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: A marriage under the arch of systems pharmacology. Clin. Pharmacol. Ther. 92, 50-61 (2012
19. Wist, A.D., Berger, S.I. & Iyengar, R. Systems pharmacology and genome medicine: A future perspective. Genome Med. 1, 11 (2009
20. Altman, R.B. Translational Bioinformatics: linking the molecular world to the clinical world. Clin. Pharmacol. Ther. 91, 994-1000 (2012
21. Kohl, P., Crampin, E.J., Quinn, T.A. & Noble, D. Systems biology: An approach. Clin. Pharmacol. Ther. 88, 25-33 (2010
22. Groves, T. & Godlee, F. Open science and reproducible research. BMJ 344, e4383 (2012
23. Conway, M. Open Access: A new model for publishing in the pharmacological sciences. CPT: Pharmacomet. Syst. Pharmacol. 1, e7 (2012
24. Royal Society. Science as an open enterprise: open data for open science. (2012
25. Li, C., Donizelli, M., Rodriguez, N., Dharuri, H., Endler, L., Chelliah, V. et al. BioModels database: An enhanced, curated and annotated resource for publishing quantitative kinetic models. BMC Syst. Biol. 4, 92 (2010
26. Vicini, P. Multiscale modeling in drug discovery and development: future opportunities and present challenges. Clin. Pharmacol. Ther. 88, 126-129 (2010
27. Ait-Oudhia, S., Lowe, P.J. & Mager, D.E. Bridging clinical outcomes of canakinumab treatment in rheumatoid arthritis patients with a population model of IL-1β kinetics. CPT: Pharmacomet. Syst. Pharmacol. 1, e5 (2012
28. Huisinga, W., Solms, A., Fronton, L. & Pilari, S. Modeling inter-individual variability in physiologically- based pharmacokinetics and its link to mechanistic covariate modeling. CPT: Pharmacomet. Syst. Pharmacol. 1, e4 (2012
29. Ke, A.B., Nallani, S.C., Zhao, P., Rostami-Hodjegan, A., Unadkat, J.D. A PBPK model to predict disposition of CYP3A-metabolized drugs in pregnant women: verification and discerning the site of CYP3A induction. CPT: Pharmacomet. Syst. Pharmacol. 1, e3 (2012
30. Quinney, S.K. et al. A semi-mechanistic metabolism model of CYP3A substrates in pregnancy: Predicting changes in midazolam and nifedipine pharmacokinetics. CPT: Pharmacomet. Syst. Pharmacol. 1, e2 (2012
31. Reddy, V.P., Petersson, K.J., Suleiman, A.A., Vermeulen, A., Proost, J.H.& Friberg, L.E. Pharmacokinetic-pharmacodynamic modeling of severity levels of extrapyramidal side effects with Markov elements. CPT: Pharmacomet. Syst. Pharmacol. 1, e6 (2012
32. Mould, D.R. & Upton, R.N. Basic concepts in population modeling and model based drug development. CPT: Pharmacomet. Syst. Pharmacol. 1, e6 (2012